J
Janux Therapeutics, Inc.
JANX · NASDAQ · Healthcare · 983M
Closing price
$18.39
-0.59% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.2×
Enterprise value / EBITDAEV/EBITDA
-9.9×
Free cash flow yieldFCF yield
-7.3%
Return on equityROE
-11.9%
Operating margin
-1576.7%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.